Company news
Corcept Therapeutics Incorporated news in 2023
Corcept Therapeutics Incorporated's news releases, calls and decks from 2023, newest first.
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
October 31, 2023
Corcept Appoints Monica Tellado as President, Emerging Markets
October 31, 2023
Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)
October 25, 2023
Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)
July 16, 2023
Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer
June 26, 2023
Corcept Therapeutics Announces Final Results of Tender Offer
April 4, 2023
Corcept Therapeutics Announces Preliminary Results of Tender Offer
April 2, 2023
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 27, 2023
Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock
March 5, 2023
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update
February 27, 2023
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call
February 13, 2023
Corcept Therapeutics Announces Preliminary Settlement of Purported Securities Class Action Litigation
February 12, 2023
Calls in 2023
- Corcept Therapeutics (NASDAQ:CORT) Q3 2023 Earnings Call
Nov 1, 2023
Transcript - Corcept Therapeutics (NASDAQ:CORT) Q2 2023 Earnings Call
Aug 2, 2023
Transcript - Corcept Therapeutics (NASDAQ:CORT) Q1 2023 Earnings Call
May 4, 2023
Transcript - Corcept Therapeutics (NASDAQ:CORT) Q4 2022 Earnings Call
Feb 28, 2023
Transcript
Decks in 2023
- Technical Presentation (April 2023)
Technical · 13 slides · Apr 14, 2023